Page 2 - Coagulation Factor News Today

/CNW/ - Novo Nordisk announced today that Health Canada has approved a new indication for REBINYN® (Coagulation Factor IX (Recombinant), pegylated) for the...

Discover the strengths and weaknesses of one of the most common types of coverage assay

Discover the strengths and weaknesses of one of the most common types of coverage assay

LONDON, Sept. 13, 2022 /PRNewswire/ -- Global Bio-Pharma Market is valued at USD 274.10 Billion in 2020 and is expected to reach USD 703.28 Billion by 2027 with a CAGR of 12.5% over the forecast

/PRNewswire/ -- Global Bio-Pharma Market is valued at USD 274.10 Billion in 2020 and is expected to reach USD 703.28 Billion by 2027 with a CAGR of 12.5% over...

On the basis of end user, the hospitals segment is likely to dominate the Vietnam plasma fractionation market in the forecast year.

Vietnam Plasma Fractionation Market Scope and overview, Study Combine With Challenges and Opportunities up to 2031 et | 2022-01-07 08:09:35

Vietnam Plasma Fractionation Market 2021 Growth Opportunities, Driving Factors by Manufacturers, Regions, Type and Application, Forecast Analysis to 2027 | 2021-12-22 04:41:43

The detailed research report on the Global Coagulation Factor IX Market focuses on the macro as well as microeconomic factors that are helping its development. The report also concentrates on the regulatory framework that is shaping the future of the global market. Furthermore, the research report also makes not of...

Human Plasma Products and Derivatives Market Swot Analysis by key players Takeda, CSL, Grifols, Octapharma